Skip to main content

Skye Bioscience, Inc. (SKYE)

OTCMKTS: SKYE · Delayed Price · USD
1.55
0.00 (0.00%)
Nov 28, 2023, 2:56 PM EST - Market closed

Skye Bioscience Market Cap

Skye Bioscience has a market cap or net worth of $1.51 billion as of November 28, 2023. Its market cap has increased by 12,061.52% in one year.

Market Cap
1.51B
Enterprise Value
1.51B
1-Year Change
12,061.52%
Ranking
n/a
Category
Small-Cap
Stock Price
$1.55

Market Cap Chart

Since January 6, 2015, Skye Bioscience's market cap has increased from $125.81M to $1.51B, an increase of 1,096.96%. That is a compound annual growth rate of 32.22%.

History

DateMarket Cap% Change
Nov 24, 20231.51B
1.97%
Nov 22, 20231.48B
-5.59%
Nov 21, 20231.56B
-4.73%
Nov 20, 20231.64B
-2.87%
Nov 17, 20231.69B
13.73%
Nov 16, 20231.49B
6.25%
Nov 15, 20231.40B
-8.86%
Nov 14, 20231.54B
-7.06%
Nov 13, 20231.65B-
Nov 10, 20231.65B-
Nov 9, 20231.65B
-5.56%
Nov 8, 20231.75B
2.86%
Nov 7, 20231.70B-
Nov 6, 20231.70B
2.94%
Nov 3, 20231.65B
4.94%
Nov 2, 20231.57B
1.25%
Nov 1, 20231.55B
-8.57%
Oct 31, 20231.70B
3.55%
Oct 30, 20231.64B
3.68%
Oct 27, 20231.58B
7.24%
Oct 26, 20231.48B
-17.84%
Oct 25, 20231.80B
-23.24%
Oct 24, 20232.34B
-7.31%
Oct 23, 20232.53B-
Oct 20, 20232.53B-
View and export this data all the way back to 2015. Start Free Trial.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 570.63B
UnitedHealth Group 506.03B
Novo Nordisk 470.41B
Johnson & Johnson 367.11B
Merck & Co. 258.14B
AbbVie 244.83B
Novartis AG 201.72B
AstraZeneca 199.94B
Market Cap Rankings